This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot2: Release 6 Ballot (2nd Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

• Content
• Examples
• Detailed Descriptions
• Mappings
• Operations
• Search Params
• Profiles
• Extensions
• R4 Conversions

15.5.7 Resource AdministrableProductDefinition - Mappings

Biomedical Research and Regulation Work Group

Maturity Level : N/A

Standards Status : Informative

Security Category : Anonymous

Compartments : No defined compartments

Mappings for the administrableproductdefinition resource (see Mappings to Other Standards for further information & status).

15.5.7.1 FiveWs Pattern Mapping ( http://hl7.org/fhir/fivews )

AdministrableProductDefinition	administrative.medication
identifier	FiveWs.class

15.5.7.2 IDMP Mapping ( https://www.iso.org/obp/ui/#iso:std:iso:11615 )

AdministrableProductDefinition	Pharmaceutical Product
identifier	PhPID
status	n/a
formOf	(link to Medicinal Product)
administrableDoseForm	Pharmaceutical Product.Administrable Dose Form
unitOfPresentation	Pharmaceutical Product.Unit of Presentation
producedFrom	n/a (this is the link from Pharmaceutical Product to the Manufactured Item(s))
ingredient	Pharmaceutical Product.Ingredient (see also FHIR Ingredient resource)
device	Pharmaceutical Product.Device
description	n/a
property	Pharmaceutical Product Characteristics
type	Pharmaceutical Product Characteristics.Code System (not a one to one map, the resource is more capable)
value[x]	Pharmaceutical Product Characteristics.Value (not a one to one map, the resource is more capable)
status	Pharmaceutical Product Characteristics.Status
routeOfAdministration	Pharmaceutical Product.Route of Administration
code	Route of Administration.Route of Administration
firstDose	Dosing and Route of Administration.First dose in humans (Investigational Medicinal Product)
maxSingleDose	Dosing and Route of Administration.Maximum single dose (Investigational Medicinal Product)
maxDosePerDay	Dosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product)
maxDosePerTreatmentPeriod	Dosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product)
maxTreatmentPeriod	Dosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product)
targetSpecies	n/a
code	n/a
withdrawalPeriod	n/a
tissue	n/a
value	n/a
supportingInformation	n/a